(80 days)
Perfudrop® Air M-P with Needle is an intravascular administration set to administer IV fluids and pharmaceuticals from a container to a patient's vascular system through a needle inserted into a vein. The administration set is for use under gravity and pressure conditions. The set is not intended nor indicated for use with blood or blood products.
The Perfudrop® Air M-P intravascular administration set (model no. 48451606) is a disposable, single-use Intravascular administration set intended for use under gravity and pressure conditions as well. The intravascular administration set uses a needle attached to the set. The design of the intravascular administration set is according to the requirements of ISO 8536-4. The design of the sterile hypodermic needle is according to the requirements of ISO 7864. The device includes a drip chamber with a 15 μm filter and a spike to penetrate and connect the tubing to an I. V. bag or other infusion fluid container, tubing, flow regulator and a connector to connect the needle to the set.
This document is a 510(k) summary for the Perfudrop® Air M-P With Needle intravascular administration set. It describes a medical device and its intended use, but it does not contain information about acceptance criteria or a study proving the device meets those criteria.
The purpose of a 510(k) submission is to demonstrate that a device is "substantially equivalent" to a legally marketed predicate device. This typically involves comparing technological characteristics and intended use. The provided text confirms the device's substantial equivalence to the predicate "Gemini IV Administration Sets" (K022209) based on its design according to ISO 8536-4 and ISO 7864 for the needle.
Therefore, I cannot provide the requested information from the provided text for the following reasons:
- No acceptance criteria are mentioned. The document focuses on regulatory approval based on substantial equivalence, not performance criteria.
- No specific study is described. There is no mention of a performance study, clinical trial, or any other investigation designed to test the device against acceptance criteria.
- The document is a regulatory submission summary, not a study report. It outlines the device's characteristics and its comparison to a predicate device for 510(k) clearance.
To answer your request, a detailed performance study report with predefined acceptance criteria would be necessary.
{0}------------------------------------------------
Medical Produkte
510(k) Notification
Section E. Summary as required by section 807.92 (c)
| Submitter: | Clinico GmbH | ||
|---|---|---|---|
| Robert-Koch-Strasse 5 | |||
| D-36251 Bad Hersfeld | |||
| Phone | (01149) 6621 - 1680 | ||
| FAX | (01149) 6621 - 168111 | ||
| Contact: | Dr. Reinhard Hopf | ||
| Manager Regulatory Affairs | |||
| Phone | (01149) 6621 - 168480 | ||
| FAX | (01149) 6621 - 168111 | ||
| HopfR@clinico.de | |||
| Date: | 07 / 07 / 2004 | ||
| Name of Device: | Perfudrop® Air M-P With Needle | ||
| Common name: | Intravascular administration set | ||
| Classificationname of device: | a) Product code: FPA | ||
| b) Regulation number: 880.5440 | |||
| Predicate device: | Gemini IV Administration Sets, | ||
| Alaris (Premarket notification K022209) | |||
| Description of theset: | The Perfudrop® Air M-P intravascular administrationset (model no. 48451606) is a disposable, single-useIntravascular administration set intended for useunder gravity and pressure conditions as well. Theintravascular administration set uses a needleattached to the set. | ||
| The design of the intravascular administration set isaccording to the requirements of ISO 8536-4.The design of the sterile hypodermic needle isaccording to the requirements of ISO 7864. |
{1}------------------------------------------------
t
| innovative | |
|---|---|
| Medical Produkte |
| Intended use of the device: | Perfudrop® Air M-P with needle is an intravascularadministration set to administer IV fluids andpharmaceuticals from a container to a patient's vascularsystem through a needle inserted into a vein. The deviceincludes a drip chamber with a 15 μm filter and a spike topenetrate and connect the tubing to an I. V. bag or otherinfusion fluid container, tubing, flow regulator and aconnector to connect the needle to the set. |
|---|---|
| The administration set is for use under gravity and pressureconditions. | |
| The set is not intended nor indicated for use with blood orblood products. | |
| Comparison of theTechnologicalFeatures of the NewDevice andPredicate Device: | The administration set "Perfudrop® Air M-P with needle"is substantially similar to the lawfully marketed predicateddevice. Both sets are intended for administration of IVfluids and pharmaceuticals from a container to apatient's vascular system. |
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the department's name around the perimeter. In the center of the seal is a stylized caduceus, a symbol often associated with medicine and healthcare. The caduceus consists of a staff with two snakes coiled around it and a pair of wings at the top.
OCT 4 - 2004
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Dr. Reinhard Hopf Manager Regulatory Affairs Clinico GmbH Robert-Koch-Strasse 5 D-36251 Bad Hersfeld
Re: K041919
Trade/Device Name: Perfudrop® Air M-P with Sterile Hypodermic Needle 20 G. Model 48451606 Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: July 12, 2004 Received: July 30, 2004
Dear Dr. Hopf:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Dr. Hopf
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Chiu Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for "clinico" with the registered trademark symbol. Below the logo, the word "innovative" is written in italics, followed by "Medical Produkte". Above the logo, there is some handwritten text that is difficult to read.
Indications for Use Statement
510(k) Number (if known): K041919
Device Name: Perfudrop® Air With Sterile Hypodermic Needle 20 G
Indications For Use:
Perfudrop® Air M-P with Needle is an intravascular administration set to administer IV fluids and pharmaceuticals from a container to a patient's vascular system through a needle inserted into a vein.
The administration set is for use under gravity and pressure conditions. The set is not intended nor indicated for use with blood or blood products.
| Prescription Use | X |
|---|---|
| (Part 21 CFR 801 Subpart D) |
AND/OR
Over - The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
signature
(Division Sign-Off) Division of Anesthesiology. General Hospital, Infection Control, Dental Device
510(k) Number
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.